AHMET MESUT ONAT

Yayın Ağı

Makaleler 12

1. Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-alpha Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence

Kisacik B., Pamuk O. N., Onat A. M., Erer S. B., Hatemi G., Ozguler Y., et al.

JOURNAL OF RHEUMATOLOGY , cilt.43, sa.3, ss.524-529, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Current antiviral practice and course of Hepatitis B virus infection in inflammatory arthritis: a multicentric observational study (A

KALYONCU U., Emmungil H., Onat A. M., Yilmaz S., Kasifoglu T., Akar S., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.2, sa.4, ss.149-154, 2015 (ESCI, TRDizin) Sürdürülebilir Kalkınma

3. The Effect of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Positivity on Drug Survival of Abatacept in Patients with Rheumatoid Arthritis in Routine Care: The Results from Turkbio Registry

Ertenli I., KARADAĞ Ö., PEHLİVAN Y., Dalkilic E., Onat A. M., Kisacik B., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

4. Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.

Kisacik B., Pamuk O., Onat A. M., Erer B., Hatemi G., Ozguler Y., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

5. Mean Platelet Volume Seems To Be a Valuable Marker in Patients with Systemic Sclerosis

Soydinc S., Turkbeyler I. H., PEHLİVAN Y., Soylu G., Goktepe M. F., Bilici M., et al.

INFLAMMATION , cilt.37, sa.1, ss.100-106, 2014 (SCI-Expanded, Scopus)

6. The Comparative One-Year Drug Survival Rate of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis; Results from Turkbio Registry

Sari I., KALYONCU U., Onat A. M., Pamuk O. N., KARADAĞ Ö., Kisacik B., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)

7. Is familial Mediterranean fever (FMF) common in patients with negative appendectomy?

Kisacik B., Karabicak I., Erol M. F., Ozer S., Pehlivan Y., Onat A. M., et al.

MODERN RHEUMATOLOGY , cilt.23, sa.2, ss.330-333, 2013 (SCI-Expanded, Scopus)

8. Detecting Subclinical Biventricular Impairment in Scleroderma Patients by Use of Pulsed-Wave Tissue Doppler Imaging

Can I., Onat A. M., AYTEMİR K., AKDOĞAN A., Ureten K., KİRAZ S., et al.

TEXAS HEART INSTITUTE JOURNAL , cilt.36, sa.1, ss.31-37, 2009 (SCI-Expanded, Scopus)

9. Cardiac repolarization abnormalities and increased, sympathetic activity in scleroderma

Ciftci O., Onat A. M., Yavuz B., Akdogan A., Aytemir K., Tokgozoglu L., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.99, sa.3, ss.232-237, 2007 (SCI-Expanded, Scopus)

10. Selective serotonin reuptake inhibitors reduce the attack frequency in familial Mediterranean fever

Onat A. M., Ozturk M. A., Ozcakar L., Ureten K., Kaymak S. U., kiraz S., et al.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE , cilt.211, sa.1, ss.9-14, 2007 (SCI-Expanded, Scopus)

11. Sonographic evaluation of the tendons in familial Mediterranean fever and Behcet's disease

Oezcakar L., Onat A. M., Uereten K., Cetin A., Sedat K., Ertenli I., et al.

JOINT BONE SPINE , cilt.73, sa.5, ss.514-517, 2006 (SCI-Expanded, Scopus)

12. Transverse myelitis in a patient with Behcet's disease: favorable outcome with a combination of interferon-alpha

ÇALGÜNERİ M., Onat A. M., ÖZTÜRK M. A., Ozcakar L., ÜRETEN K., Akdogan A., et al.

CLINICAL RHEUMATOLOGY , cilt.24, sa.1, ss.64-66, 2005 (SCI-Expanded, Scopus)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

173

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler